ULBI - Ultralife Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
89,536
87,190
85,531
82,460
76,427
Cost of Revenue
63,836
61,607
59,299
57,352
53,111
Gross Profit
25,700
25,583
26,232
25,108
23,316
Operating Expenses
Research Development
4,813
4,508
4,737
5,946
5,603
Selling General and Administrative
14,730
14,520
15,019
15,399
14,233
Total Operating Expenses
19,543
19,028
19,756
21,345
19,836
Operating Income or Loss
6,157
6,555
6,476
3,763
3,480
Interest Expense
128
63
183
263
248
Total Other Income/Expenses Net
93
58
-181
-183
-85
Income Before Tax
6,122
6,613
6,295
3,580
3,150
Income Tax Expense
-17,802
-18,386
-1,369
98
310
Income from Continuing Operations
23,924
24,999
7,664
3,482
2,840
Net Income
23,834
24,930
7,648
3,509
2,869
Net Income available to common shareholders
23,834
24,930
7,648
3,509
2,869
Reported EPS
Basic
-
1.57
0.49
0.23
0.18
Diluted
-
1.53
0.48
0.23
0.17
Weighted average shares outstanding
Basic
-
15,882
15,528
15,261
16,182
Diluted
-
16,347
15,858
15,405
16,419
EBITDA
-
6,555
6,476
3,763
3,398